Literature DB >> 11435579

Genomic stability of murine leukemia viruses containing insertions at the Env-3' untranslated region boundary.

C R Logg1, A Logg, C K Tai, P M Cannon, N Kasahara.   

Abstract

Retroviruses containing inserts of exogenous sequences frequently eliminate the inserted sequences upon spread in susceptible cells. We have constructed replication-competent murine leukemia virus (MLV) vectors containing internal ribosome entry site (IRES)-transgene cassettes at the env-3' untranslated region boundary in order to examine the effects of insert sequence and size on the loss of inserts during viral replication. A virus containing an insertion of 1.6 kb replicated with greatly attenuated kinetics relative to wild-type virus and lost the inserted sequences in a single infection cycle. In contrast, MLVs containing inserts of 1.15 to 1.30 kb replicated with kinetics only slightly attenuated compared to wild-type MLV and exhibited much greater stability, maintaining their genomic integrity over multiple serial infection cycles. Eventually, multiple species of deletion mutants were detected simultaneously in later infection cycles; once detected, these variants rapidly dominated the population and thereafter appeared to be maintained at a relative equilibrium. Sequence analysis of these variants identified preferred sites of recombination in the parental viruses, including both short direct repeats and inverted repeats. One instance of insert deletion through recombination with an endogenous retrovirus was also observed. When specific sequences involved in these recombination events were eliminated, deletion variants still arose with the same kinetics upon virus passage and by apparently similar mechanisms, although at different locations in the vectors. Our results suggest that while lengthened, insert-containing genomes can be maintained over multiple replication cycles, preferential deletions resulting in loss of the inserted sequences confer a strong selective advantage.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11435579      PMCID: PMC114427          DOI: 10.1128/JVI.75.15.6989-6998.2001

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  60 in total

1.  Presence of chicken tumour virus in the sarcoma of the adult rat inoculated after birth with Rous sarcoma tissue.

Authors:  J SVOBODA
Journal:  Nature       Date:  1960-06-18       Impact factor: 49.962

2.  Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination.

Authors:  W S Hu; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction.

Authors:  S A Herman; J M Coffin
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

4.  The accuracy of reverse transcriptase from HIV-1.

Authors:  J D Roberts; K Bebenek; T A Kunkel
Journal:  Science       Date:  1988-11-25       Impact factor: 47.728

5.  Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.

Authors:  R M Horton; H D Hunt; S N Ho; J K Pullen; L R Pease
Journal:  Gene       Date:  1989-04-15       Impact factor: 3.688

6.  A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation.

Authors:  S K Jang; H G Kräusslich; M J Nicklin; G M Duke; A C Palmenberg; E Wimmer
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Genetic recombination of human immunodeficiency virus.

Authors:  F Clavel; M D Hoggan; R L Willey; K Strebel; M A Martin; R Repaske
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

8.  Nondefective spleen necrosis virus-derived vectors define the upper size limit for packaging reticuloendotheliosis viruses.

Authors:  C Gélinas; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Construction and use of a replication-competent human immunodeficiency virus (HIV-1) that expresses the chloramphenicol acetyltransferase enzyme.

Authors:  E F Terwilliger; B Godin; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

10.  Construction and properties of replication-competent murine retroviral vectors encoding methotrexate resistance.

Authors:  H Stuhlmann; R Jaenisch; R C Mulligan
Journal:  Mol Cell Biol       Date:  1989-01       Impact factor: 4.272

View more
  33 in total

1.  An RNA secondary structure bias for non-homologous reverse transcriptase-mediated deletions in vivo.

Authors:  Mogens Duch; Maria L Carrasco; Thomas Jespersen; Lars Aagaard; Finn Skou Pedersen
Journal:  Nucleic Acids Res       Date:  2004-04-06       Impact factor: 16.971

2.  Optimization of enzyme-substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferases.

Authors:  Takahiro Kimura; Kei Hiraoka; Noriyuki Kasahara; Christopher R Logg
Journal:  J Gene Med       Date:  2010-06       Impact factor: 4.565

Review 3.  Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Authors:  Kurt M Kroeger; A K M Ghulam Muhammad; Gregory J Baker; Hikmat Assi; Mia K Wibowo; Weidong Xiong; Kader Yagiz; Marianela Candolfi; Pedro R Lowenstein; Maria G Castro
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

4.  Extensive Replication of a Retroviral Replicating Vector Can Expand the A Bulge in the Encephalomyocarditis Virus Internal Ribosome Entry Site and Change Translation Efficiency of the Downstream Transgene.

Authors:  Amy H Lin; Yanzheng Liu; Cynthia Burrascano; Kathrina Cunanan; Christopher R Logg; Joan M Robbins; Noriyuki Kasahara; Harry Gruber; Carlos Ibañez; Douglas J Jolly
Journal:  Hum Gene Ther Methods       Date:  2016-02-26       Impact factor: 2.396

Review 5.  Oncolytic viruses: From bench to bedside with a focus on safety.

Authors:  Pascal R A Buijs; Judith H E Verhagen; Casper H J van Eijck; Bernadette G van den Hoogen
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Retroviral replicating vectors in cancer.

Authors:  Christopher R Logg; Joan M Robbins; Douglas J Jolly; Harry E Gruber; Noriyuki Kasahara
Journal:  Methods Enzymol       Date:  2012       Impact factor: 1.600

7.  Tissue- and tumor-specific targeting of murine leukemia virus-based replication-competent retroviral vectors.

Authors:  Christian Metzl; Daniela Mischek; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 8.  Selective gene silencing by viral delivery of short hairpin RNA.

Authors:  Katja Sliva; Barbara S Schnierle
Journal:  Virol J       Date:  2010-09-21       Impact factor: 4.099

9.  Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing.

Authors:  Christopher R Logg; Brian T Baranick; Nathan A Lemp; Noriyuki Kasahara
Journal:  J Mol Biol       Date:  2007-04-19       Impact factor: 5.469

10.  Influence of vector design and host cell on the mechanism of recombination and emergence of mutant subpopulations of replicating retroviral vectors.

Authors:  Matthias Paar; Dieter Klein; Brian Salmons; Walter H Günzburg; Matthias Renner; Daniel Portsmouth
Journal:  BMC Mol Biol       Date:  2009-02-09       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.